rs587779458
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000090.4(COL3A1):c.2069G>A(p.Gly690Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G690R) has been classified as Pathogenic.
Frequency
Consequence
NM_000090.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
COL3A1 | NM_000090.4 | c.2069G>A | p.Gly690Glu | missense_variant | 30/51 | ENST00000304636.9 | NP_000081.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
COL3A1 | ENST00000304636.9 | c.2069G>A | p.Gly690Glu | missense_variant | 30/51 | 1 | NM_000090.4 | ENSP00000304408.4 | ||
COL3A1 | ENST00000450867.2 | c.1970G>A | p.Gly657Glu | missense_variant | 29/50 | 1 | ENSP00000415346.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1439788Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 714156
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Familial thoracic aortic aneurysm and aortic dissection Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 13, 2017 | The p.G690E variant (also known as c.2069G>A), located in coding exon 30 of the COL3A1 gene, results from a G to A substitution at nucleotide position 2069. The glycine at codon 690 is replaced by glutamic acid, an amino acid with similar properties, and is located in the triple-helical domain. Other alterations affecting this amino acid (p.G690R, c.2068G>A and p.G690V, c.2069G>T) have been detected in a vascular Ehlers-Danlos syndrome cohort (Pepin MG. Genet Med. 2014;16(12):881-8). The majority (approximately two-thirds) of COL3A1 mutations identified to date have involved the substitution of another amino acid for glycine within the triple-helical domain (Schwarze U et al. Am J Hum Genet. 1997;61(6):1276-1286; Pepin MG et al. Genet Med. 2014;16(12):881-8). In addition, internal structural analysis indicates that this alteration would disrupt the characteristic motif of collagen, and insert a bulky sidechain into a sterically constrained region (Bella J et al. Science. 1994;266(5182):75-81; Hohenester E et al. Proc Natl Acad Sci U.S.A. 2008;105(47):18273-7). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at